NAWAIWAQT GROUP
 
 
 
Model spends $100k on surgery to look like doll
 
 
 

Tokyo   DM - A Japanese woman has undergone a startling physical transformation that has so far involved more than 30 cosmetic procedures at a cost of 10 million yen or $102,000.
The lady, a model known as Vanilla Chamu, has said she intends to keep having surgeries until she has achieved her lifelong goal – to look like a French doll.
Photos of Vanilla prior to her first procedures reveal a rather mousy Japanese teenager whose facial features are virtually unrecognizable from the bizarre and undoubtedly more ‘western-looking’ appearance that she now possesses.
Certain plastic surgery treatments, including double-eyelid surgery and nose jobs, are increasingly popular amongst Asian woman wishing to look more western.
Vanilla has unquestionably had those treatments, but her long list of procedures also includes liposuction, eyelash implants, dimple creation, reports BuzzFeed.
Still her current look isn’t enough for Vanilla in her quest to become a ‘perfect living French doll’. She plans to undergo height lengthening surgery. Vanilla underwent her first plastic surgery when she was 19 years old and keeps her current age a well-guarded secret. She has become something of a cause célèbre in her native land, making countless television appearances and launching a pop career.
Her unusual appearance undoubtedly makes her guaranteed to stand out in any crowd, but she does possess a very unusual view of what a French doll should look like.
A French doll can also be known as a porcelain doll, bisque doll or china doll and means a doll partially or wholly out of bisque porcelain.
Traditionally they are characterized by their realistic, skin-like matte finish and were at the peak of their popularity between 1860 and 1900. Such dolls are now highly collectible and worth thousands of US dollars.

 
 
on epaper page 19
 
Topics
 
model spends surgery doll
 
more in Snippets

New York  - Better educated women have lower levels of ‘bad cholesterol’ th...

WASHINGTON - An experimental drug from Swiss pharma giant Novartis reduced deaths from chron...

 
Comments
comments powered by Disqus
 
 
NAWAIWAQT GROUP